This pilot study was undertaken to assess the feasibility of obtaining prevalence data on chronic disease conditions using data that is recorded by practitioners during episodes of care, rather than providing a comprehensive snapshot of the population.
Although we have not presented data by disease condition, E coli represents the vast majority of UTIs.
Data on co-morbid disease conditions and risk factors were obtained on an anamnestic basis from the treating physician, but diagnoses were not objectively verified.
Data on co-morbid disease conditions and risk factors were obtained on an anamnestic basis from the treating physician but diagnoses were not objectively verified independently within this registry.
For example, we can use microarray data from different health and disease conditions, such as cancer and non-cancer, to create networks specific to those contexts.
For sensitivity and specificity analysis, the blood culture data define the disease condition (infection).
Table 1 summarizes demographic data, baseline chronic disease condition, use of ACEI or ARA, daily urinary urea and protein levels, and body lead burden for participants in each group.
In our previous work [7], we have developed a contemporaneous health index (CHI) that fuses the irregular multivariate longitudinal time series data to quantify the severity of degenerative disease conditions to fit the monotonic degradation process of the disease condition.
For biomedical data, for example, attributes like experimental protocols followed, technologies used, disease conditions investigated and genes involved could all be necessary to make the data meaningful.
In diabetes, a multidimensional approach to data analysis is needed to better understand the disease conditions, trajectories and the associated comorbidities.
